Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Eurofins Scientific SE logo
ERF.PA
Eurofins Scientific SE
13:11:34
62.56 €
0.0000 (%0.00)
Previous Close: 62.88
Day Low₺62.52
Day High₺63.24
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

ERF.PA: Eurofins Scientific SE Financials

Eurofins Scientific SE Income Statement

Total revenue
Net income
Gross margin TTM
10.87%
Operating margin TTM
10.87%
Net profit margin TTM
6.51%
Return on investment TTM
13.41%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue7,296,000,0006,951,000,0006,514,600,0006,712,100,000
Operating income793,000,000726,200,000546,800,000783,200,000
Net income475,000,000406,400,000310,300,000610,200,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue7,296,000,0006,951,000,0006,514,600,0006,712,100,000
Cost of revenue6,503,000,0002,238,800,0005,894,200,0002,227,000,000
Gross profit793,000,0004,712,200,000620,400,0004,485,100,000
Research and development expenses0000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses067,800,00073,600,00039,400,000
Other expenses03,986,000,00003,662,500,000
Operating expenses4,151,800,0003,986,000,00073,600,0003,701,900,000
Cost and expenses6,503,000,0006,224,800,0005,967,800,0005,928,900,000
Net interest income-131,000,000-131,500,000-117,800,000-103,900,000
Interest income35,000,00019,300,00011,600,0002,200,000
Interest expense166,000,000150,800,000129,400,000105,600,000
Depreciation and amortization630,000,000691,400,000664,300,000607,200,000
EBITDA1,449,000,0001,381,700,0001,217,000,0001,474,600,000
EBIT819,000,000695,300,000552,700,000885,600,000
Non-operating income (excl. interest)-26,000,00030,900,000-5,900,000-102,400,000
Operating income793,000,000726,200,000546,800,000783,200,000
Total other income/expenses (net)-139,000,000-171,600,000-123,500,000-3,200,000
Income before tax654,000,000554,600,000423,300,000780,000,000
Income tax expense181,000,000149,100,000115,500,000174,200,000
Net income from continuing operations473,000,000405,500,000307,800,000604,900,000
Net income from discontinued operations0000
Other adjustments to net income000900,000
Net income475,000,000406,400,000310,300,000610,200,000
Net income deductions00-100,0000
Bottom line net income475,000,000406,400,000310,200,000610,200,000
EPS3223
Diluted EPS3223
Weighted average shares outstanding180,000,000190,600,000192,900,000192,500,000
Weighted average diluted shares outstanding187,000,000194,500,000197,900,000199,000,000

Eurofins Scientific SE Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
4,705,000,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets10,985,000,00010,888,400,00010,888,600,00010,083,500,000
Total liabilities7,399,000,0005,503,600,0005,751,200,0005,232,500,000
Total equity3,543,000,0005,339,000,0005,077,500,0004,782,100,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents791,000,000613,900,0001,221,200,000486,600,000
Short-term investments0000
Cash and short-term investments791,000,000613,900,0001,221,200,000486,600,000
Net receivables1,537,000,0001,507,100,0001,617,000,0001,597,200,000
Accounts receivable1,421,000,0001,094,400,0001,380,500,0001,341,700,000
Other receivables116,000,000412,700,000236,500,000255,500,000
Inventory139,000,000141,900,000139,000,000145,600,000
Prepaid expenses76,100,00085,700,00084,900,00078,300,000
Other current assets186,000,000103,600,0004,300,0005,600,000
Total current assets2,653,000,0002,452,200,0003,066,400,0002,313,300,000
Property, plant and equipment (net)2,763,000,0002,559,800,0002,297,400,0002,167,700,000
Goodwill4,657,000,0004,840,700,0004,551,400,0004,524,100,000
Intangible assets690,000,000787,900,000796,000,000919,000,000
Goodwill and intangible assets5,347,000,0005,628,600,0005,347,400,0005,443,100,000
Long-term investments105,000,000117,200,00083,600,00083,600,000
Tax assets116,000,000130,300,00093,800,00075,700,000
Other non-current assets1,000,000200,0000100,000
Total non-current assets8,332,000,0008,436,100,0007,822,200,0007,770,200,000
Other assets0100,00000
Total assets10,985,000,00010,888,400,00010,888,600,00010,083,500,000
Total payables708,000,0001,402,800,000626,900,000682,400,000
Accounts payable678,000,000645,900,000600,200,000647,700,000
Other payables30,000,000756,900,00026,700,00034,700,000
Accrued expenses0000
Short-term debt727,000,000328,600,000458,300,00085,200,000
Capital lease obligations (current)137,800,000150,200,000142,700,000128,600,000
Tax payables0598,100,00026,700,000540,100,000
Deferred revenue217,000,000195,900,000192,800,000184,200,000
Other current liabilities778,000,000228,600,000701,000,000691,800,000
Total current liabilities2,430,000,0002,110,200,0002,121,700,0001,772,200,000
Long-term debt4,705,000,0002,674,200,0002,889,400,0002,712,800,000
Capital lease obligations (non-current)298,100,000457,300,000436,100,000399,000,000
Deferred revenue (non-current)0000
Deferred tax liabilities (non-current)121,000,000109,500,000110,000,000133,600,000
Other non-current liabilities143,000,000152,400,000194,000,000214,900,000
Total non-current liabilities4,969,000,0003,393,400,0003,629,500,0003,460,300,000
Other liabilities0000
Capital lease obligations435,900,000607,500,000578,800,000527,600,000
Total liabilities7,399,000,0005,503,600,0005,751,200,0005,232,500,000
Treasury stock-299,000,000-307,800,000-54,900,000-14,200,000
Preferred stock0000
Common stock2,000,0001,900,0001,900,0001,900,000
Retained earnings3,024,000,0002,692,200,0002,393,800,0002,333,000,000
Additional paid-in capital0000
Accumulated other comprehensive income/loss-247,000,0002,952,700,0001,736,700,0002,461,400,000
Other stockholders' equity1,063,000,00001,000,000,0000
Total stockholders' equity3,543,000,0005,339,000,0005,077,500,0004,782,100,000
Total equity3,576,000,0005,384,800,0005,137,400,0004,851,000,000
Minority interest33,000,00045,800,00059,900,00068,900,000
Total liabilities and total equity10,985,000,00010,888,400,00010,888,600,00010,083,500,000
Total investments105,000,000117,400,00083,600,00083,600,000
Total debt5,432,000,0003,610,300,0003,926,500,0003,325,500,000
Net debt4,641,000,0002,996,400,0002,705,300,0002,838,900,000

Eurofins Scientific SE Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations1,295,000,0001,318,900,0001,017,900,0001,136,300,000
Cash from investing-1,087,000,000-846,500,000-681,100,000-855,900,000
Cash from financing13,000,000-1,089,500,000413,600,000-311,300,000
Net change in cash260,400,000-607,700,000737,700,000-31,800,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income475,000,000554,600,000310,300,000780,000,000
Depreciation and amortization630,000,000596,900,000565,000,000504,400,000
Deferred income tax0000
Stock-based compensation138,100,000138,300,000122,600,000136,100,000
Change in working capital51,000,00051,400,000-75,700,00033,000,000
Accounts receivable037,200,000-20,000,000-9,000,000
Inventory03,600,00011,000,0008,600,000
Accounts payable0-25,900,000-41,400,00020,100,000
Other working capital51,000,00038,400,000-25,300,00013,300,000
Other non-cash items139,000,000-22,300,00095,700,000-317,200,000
Net cash from operating activities1,295,000,0001,318,900,0001,017,900,0001,136,300,000
Investments in property, plant and equipment-835,000,000-453,600,000-478,100,000-660,200,000
Acquisitions (net)-250,000,000-344,300,000-150,800,000-214,700,000
Purchases of investments000-1,500,000
Sales/maturities of investments0001,500,000
Other investing activities-2,000,000-48,600,000-52,200,00019,000,000
Net cash from investing activities-1,087,000,000-846,500,000-681,100,000-855,900,000
Net debt issuance911,000,000-359,700,000548,500,000551,000,000
Long-term net debt issuance0-359,700,000548,500,000551,000,000
Short-term net debt issuance911,000,000000
Net stock issuance-543,000,000-271,700,000-47,800,000-1,200,000
Net common stock issuance-543,000,000-271,700,000-47,800,000-1,200,000
Common stock issuance397,000,000200,0008,000,00014,600,000
Common stock repurchased-940,000,000-271,900,000-55,800,000-15,800,000
Net preferred stock issuance0000
Net dividends paid-110,000,000-95,600,000-191,900,000-192,100,000
Common dividends paid-110,000,000-95,600,000-191,900,000-192,100,000
Preferred dividends paid0000
Other financing activities-245,000,000-362,500,000104,800,000-669,000,000
Net cash from financing activities13,000,000-1,089,500,000413,600,000-311,300,000
Effect of FX changes on cash39,400,0009,400,000-12,700,000-800,000
Net change in cash260,400,000-607,700,000737,700,000-31,800,000
Cash at end of period791,000,000613,200,0001,220,900,000483,200,000
Cash at beginning of period530,600,0001,220,900,000483,200,000515,000,000
Operating cash flow1,295,000,0001,318,900,0001,017,900,0001,136,300,000
Capital expenditure-760,000,000-528,400,000-550,100,000-660,200,000
Free cash flow535,000,000790,500,000467,800,000476,100,000
Income taxes paid0000
Interest paid0000